APA

Goldberg S. L., Fenaux P., Craig M. D., Gyan E., Lister J., Kassis J., Pigneux A., Schiller G. J., Jung J., Jane Leonard E., Fingert H. & Westervelt P. (20140728). An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. : Leukemia research reports.

Chicago

Goldberg Stuart L, Fenaux Pierre, Craig Michael D, Gyan Emmanuel, Lister John, Kassis Jeannine, Pigneux Arnaud, Schiller Gary J, Jung JungAh, Jane Leonard E, Fingert Howard and Westervelt Peter. 20140728. An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. : Leukemia research reports.

Harvard

Goldberg S. L., Fenaux P., Craig M. D., Gyan E., Lister J., Kassis J., Pigneux A., Schiller G. J., Jung J., Jane Leonard E., Fingert H. and Westervelt P. (20140728). An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. : Leukemia research reports.

MLA

Goldberg Stuart L, Fenaux Pierre, Craig Michael D, Gyan Emmanuel, Lister John, Kassis Jeannine, Pigneux Arnaud, Schiller Gary J, Jung JungAh, Jane Leonard E, Fingert Howard and Westervelt Peter. An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. : Leukemia research reports. 20140728.